☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update - September 2012

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for September 2012 (PDF).

This update contains drug safety information informing clinicians that dipeptidylpeptidase-4 (DPP-4) inhibitors or gliptins have been associated with an increased risk of pancreatitis. It is advised that patients are informed of the characteristic symptoms of acute pancreatitis and seek healthcare advice should these symptoms develop. If acute pancreatitis is suspected the gliptin should be stopped and a YellowCard completed.

This section also advises that the strength of oseltamivir oral suspension (Tamiflu®) will change this autumn to 6mg/ml. A new dosing dispenser will also become available but clinicians should be aware of this change and should warn patients the product is now different if it has been used it previously.

The stop press section contains updated advice on the place in therapy for levofloxacin in the treatment of acute bacterial sinusitis, acute exacerbation of chronic bronchitis, community acquired pneumonia or complicated skin and soft tissue infections. The safety profile of levofloxacin restricts it to use when other medicines cannot be prescribed or have been ineffective.

Action: Clinicians will find this publication to be a useful review of current issues in drug safety.

Share 'Drug Safety Update - September 2012' by emailShare 'Drug Safety Update - September 2012' on FacebookShare 'Drug Safety Update - September 2012' on TwitterShare 'Drug Safety Update - September 2012' on LinkedInShare 'Drug Safety Update - September 2012' on reddit


One Comment to “Drug Safety Update - September 2012”

  1. […] BNF and BNFC apps and BNF and BNFC content on NICE Evidence are updated monthly. More clinicians are using these […]

    Pingback by Changes to BNF distribution | Prescribing Advice for GPs — April 25, 2020 #

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.